Metropolis Healthcare · NSE: METROPOLIS · BSE: 542650
Q4 FY24 results · Jan–Mar 2024
Metropolis Healthcare reported revenue from operations of ₹331.00 crore (up 17.1% from Q4 FY23) and net profit of ₹36.53 crore (up 9.1% from Q4 FY23) for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 331.00 | 282.55 | +17.1% | 291.12 | +13.7% |
| Other income | 2.54 | 1.23 | +107.1% | 2.31 | +10.1% |
| Total income | 333.54 | 283.77 | +17.5% | 293.42 | +13.7% |
| Profit before tax | 50.53 | 41.90 | +20.6% | 36.85 | +37.1% |
| Net profit for the period | 36.53 | 33.49 | +9.1% | 27.29 | +33.8% |
| Attributable to shareholders of the company | 36.41 | 33.36 | +9.1% | 27.16 | +34.1% |
| EPS, basic (₹) | 7.11 | 6.50 | +9.3% | 5.30 | +34.2% |
| Net margin (%) | 11.0 | 11.9 | 9.4 |
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 292.27 | 264.41 | +10.5% | 269.41 | +8.5% |
| Other income | 2.02 | 9.14 | −77.9% | 5.19 | −61.1% |
| Total income | 294.29 | 273.54 | +7.6% | 274.60 | +7.2% |
| Profit before tax | 45.05 | 48.32 | −6.8% | 34.63 | +30.1% |
| Net profit for the period | 31.78 | 39.93 | −20.4% | 26.70 | +19.0% |
| EPS, basic (₹) | 6.21 | 7.80 | −20.4% | 5.21 | +19.1% |
| Net margin (%) | 10.9 | 15.1 | 9.9 |
Consolidated
- Filed with BSE
- 23 May 2024, 10:50 IST
- Board meeting
- 21 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 23 May 2024, 10:50 IST
- Board meeting
- 21 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE